Table 1.
Clinical and demographic characteristic
| Variable |
Group
|
|||
|---|---|---|---|---|
| Positive MOG (n = 12) | Negative MOG (n = 59) | All patients (n = 71) | P | |
| Age (year) | 30.5 [23.5-33.7] | 33.0 [29.0-40.0] | 33.0 [28.0-39.0] | 0.208 |
| Gender | ||||
| Men | 2 (16.7) | 17 (28.8) | 19 (26.8) | 0.494 |
| Women | 10 (83.3) | 42 (71.2) | 52 (73.2) | |
| Family history | 2 (16.7) | 3 (5.1) | 5 (7.0) | 0.196 |
| EDSS score at onset | 2.0 [1.5-2.5] | 2.0 [2.0-2.5] | 2.0 [2.0-2.5] | 0.537 |
| Other autoimmune disease | 1 (8.3) | 4 (6.8) | 6 (8.5) | 0.999 |
| Relapse | 2 (16.7) | 13 (22.0) | 15 (21.1) | 0.731 |
| Time of relapse (month) | 16.0 [12] | 12.0 [7.0-24.0] | 12.0 [8.0-24.0] | 0.946 |
| Last EDSS score | 1.5 [1.0-2.0] | 1.5 [1.0-2.0] | 1.5 [1.0-2.0] | 0.743 |
| First symptoms | ||||
| Sensory | 1 (8.3) | 11 (18.6) | 12 (16.9) | 0.460 |
| Motor | 11 (91.7) | 48 (81.4) | 59 (83.1) | |
| Motor presentations | ||||
| Paraparesis | 10 (90.9) | 33 (68.8) | 43 (72.9) | 0.259 |
| Quadriparesis | 1 (9.1) | 15 (31.3) | 16 (27.1) | |
| Urinary incontinence | 2 (16.7) | 6 (10.2) | 8 (11.3) | 0.615 |
| Visual | 3 (25.0) | 15 (25.4) | 18 (25.4) | 0.999 |
| Abnormal MRI | 5 (41.7) | 36 (61.0) | 41 (57.7) | 0.216 |
| Follow duration (month) | 9.0 [3.0-12.0] | 12.0 [3.0-24.0] | 12.0 [3.0-24.0] | 0.452 |
Data are presented as number (percent) and median [interquartile range (IQR)]
MOG: Myelin oligodendrocyte glycoprotein; EDSS: Expanded Disability Status Scale; MRI: Magnetic resonance imaging